Conarium Bioworks Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Seed

  • Investors
  • 3

Conarium Bioworks General Information

Description

Operator of a biotechnology company intended to produce melatonin and related hormones sustainably. The company offers bio-manufactured melatonin, HTP, and serotonin, enabling customers to access natural, pure products without chemical residues or toxic impurities.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 3128 Argent Pathway
  • Ellicott City, MD 21042
  • United States
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Corporate Office
  • 3128 Argent Pathway
  • Ellicott City, MD 21042
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Conarium Bioworks Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 30-Nov-2022 Completed Generating Revenue
1. University Spin-Out 17-Feb-2021 Completed Generating Revenue
To view Conarium Bioworks’s complete valuation and funding history, request access »

Conarium Bioworks Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Double Bioventures Venture Capital Minority
TEDCO Venture Capital Minority
Technical University of Denmark University Minority
To view Conarium Bioworks’s complete investors history, request access »

Conarium Bioworks FAQs

  • When was Conarium Bioworks founded?

    Conarium Bioworks was founded in 2021.

  • Where is Conarium Bioworks headquartered?

    Conarium Bioworks is headquartered in Ellicott City, MD.

  • What industry is Conarium Bioworks in?

    Conarium Bioworks’s primary industry is Biotechnology.

  • Is Conarium Bioworks a private or public company?

    Conarium Bioworks is a Private company.

  • What is Conarium Bioworks’s current revenue?

    The current revenue for Conarium Bioworks is .

  • Who are Conarium Bioworks’s investors?

    Double Bioventures, TEDCO, and Technical University of Denmark have invested in Conarium Bioworks.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process